4D Molecular Therapeutics Inc - ESG Rating & Company Profile powered by AI

Industry Group:Pharmaceuticals

Scroll down to the end of this page for potential risks for 4D Molecular Therapeutics Inc based on sector, location and marketcap. Comprehensive ESG assessment of 4D Molecular Therapeutics Inc are accessed by signing up for free. This page contains a questions and answers section for 4D Molecular Therapeutics Inc.

4D Molecular Therapeutics Inc in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 4.1; made up of an environmental score of 1.6, social score of 2.7 and governance score of 8.0.

green chameleon

1/10 free views/searches used

You're viewing a Free Open ESG Rating.
To access the most comprehensive ESG data experience, Sign up to SEVVA Platform.

SDG Transparency Score for 4D Molecular Therapeutics Inc 
Low
0 - 3

4.1

Medium Impact
4 - 6
High
7 - 10
Last Score Update: 2022-07-01
What drives the score for 4D Molecular Therapeutics Inc 
1.6

Environmental

2.7

Social

8.0

Governance

Detailed ESG Breakdown
SEVVA Platform offers unique drill down to the underlying sources powering the ratings. Break down your ESG analysis by 17 UN SDGs and 8 additional governance factors.

Peer Group Comparison

RankCompanySDG Transparency Score Performance
1Novartis AG
9.8
High
2Eli Lilly and Co
9.5
High
1502Zhejiang Anglikang Pharmaceutical Co Ltd
4.2
High
1502Zhejiang Jiuzhou Pharmaceutical Co Ltd
4.2
High
15514D Molecular Therapeutics Inc
4.1
High
1551CytRx Corp
4.1
High
1551Landos Biopharma Inc
4.1
High
.........
2690Zyden Gentec Ltd
0.0
Low
2690Zyla Life Sciences
0.0
Low
.........
View the full peer group of 3274 companies on the SEVVA platformSign up for free
Peer Companies Benchmark
SEVVA Platform benchmarks each company against a peer group. View the full score distribution for peers by logging into SEVVA

Frequently Asked Questions

Does 4D Molecular Therapeutics Inc reference operational or capital allocation in relation to climate change?No
No answer found for the question
Does the Board describe its role in the oversight of climate-related risks and opportunities?No
No answer found for the question

Has 4D Molecular Therapeutics Inc submitted or committed to submit to a shareholder vote (say-on-climate) its climate strategy?

Only SubscribersSubscription required

Is Capital Expenditure linked to emissions reduction?

Only SubscribersSubscription required
Does 4D Molecular Therapeutics Inc disclose current and historical air emissions?

Does 4D Molecular Therapeutics Inc disclose current and / or historical ozone-depleting emissions?

LockedSign up for free to unlock
Does 4D Molecular Therapeutics Inc disclose current and / or historical scope 1 emissions?
Does 4D Molecular Therapeutics Inc disclose current and / or historical scope 2 emissions?

Does 4D Molecular Therapeutics Inc disclose current and / or historical scope 3 emissions?

Only SubscribersSubscription required

Does 4D Molecular Therapeutics Inc disclose current and / or historical emissions broken down by scope?

Only SubscribersSubscription required
Does 4D Molecular Therapeutics Inc disclose GHG and Air Emissions intensity?

Does 4D Molecular Therapeutics Inc disclose GHG Targets?

LockedSign up for free to unlock

Does 4D Molecular Therapeutics Inc disclose data for NOx, SOx and VOCs emissions?

LockedSign up for free to unlock

Does 4D Molecular Therapeutics Inc disclose its Scope Emissions targets?

Only SubscribersSubscription required
Does 4D Molecular Therapeutics Inc disclose current and historical energy intensity?

Does 4D Molecular Therapeutics Inc disclose its current and / or historical energy use?

LockedSign up for free to unlock

Does 4D Molecular Therapeutics Inc disclose energy use targets?

LockedSign up for free to unlock

Does 4D Molecular Therapeutics Inc disclose its Renewable Energy targets?

Only SubscribersSubscription required

Does 4D Molecular Therapeutics Inc disclose its biodiversity policy?

LockedSign up for free to unlock

Does 4D Molecular Therapeutics Inc disclose its forestry policy?

LockedSign up for free to unlock

Does 4D Molecular Therapeutics Inc disclose its internal carbon price?

Only SubscribersSubscription required

Does 4D Molecular Therapeutics Inc disclose long-term targets (>5 years) for reducing its GHG emissions?

LockedSign up for free to unlock

Does 4D Molecular Therapeutics Inc disclose Scope 3 emissions from use of sold products?

Only SubscribersSubscription required

Does 4D Molecular Therapeutics Inc disclose current and historical material use?

LockedSign up for free to unlock
Are Operating Expesnses linked to emissions reduction?
Does 4D Molecular Therapeutics Inc disclose climate scenario or pathway analysis?
Does 4D Molecular Therapeutics Inc reflect climate-related risks in its financial statements?

Does 4D Molecular Therapeutics Inc disclose the number and percentage of companies screened by environmental and social criteria?

Only SubscribersSubscription required

Are emissions metrics verified by CDP?

Only SubscribersSubscription required

Are emissions metrics verified by STBi?

Only SubscribersSubscription required
Does 4D Molecular Therapeutics Inc report according to TCFD requirements?

Does 4D Molecular Therapeutics Inc disclose current and historical waste generation?

LockedSign up for free to unlock

Does 4D Molecular Therapeutics Inc disclose current and / or historical waste management?

Only SubscribersSubscription required

Does 4D Molecular Therapeutics Inc disclose waste targets?

Only SubscribersSubscription required

Has 4D Molecular Therapeutics Inc published clear targets on waste management?

LockedSign up for free to unlock

Does 4D Molecular Therapeutics Inc disclose current and / or historical water consumption?

Only SubscribersSubscription required
Does 4D Molecular Therapeutics Inc disclose its waste policy?
Does 4D Molecular Therapeutics Inc disclose water use targets?
Does 4D Molecular Therapeutics Inc condunt supply chain audits?

Does 4D Molecular Therapeutics Inc engage third parties to conduct supply chain audit?

LockedSign up for free to unlock

Does 4D Molecular Therapeutics Inc disclose board meeting attendance?

LockedSign up for free to unlock

Are there worker representatives on the board?

LockedSign up for free to unlock

Does 4D Molecular Therapeutics Inc disclose long term financial targets?

Only SubscribersSubscription required

Does 4D Molecular Therapeutics Inc report NPS (customer loyalty, customer churn or satisfaction surveys) ?

LockedSign up for free to unlock

Does 4D Molecular Therapeutics Inc report customer churn rates?

Only SubscribersSubscription required

Does 4D Molecular Therapeutics Inc have a policy relating to cyber security?

LockedSign up for free to unlock
Does 4D Molecular Therapeutics Inc disclose cybersecurity risks?

Does 4D Molecular Therapeutics Inc adhere to ISO 27001 / ISO 27002 standards or the NIST cybersecurity framework?

Only SubscribersSubscription required

Does 4D Molecular Therapeutics Inc conduct cybersecurity training?

Only SubscribersSubscription required
Does 4D Molecular Therapeutics Inc disclose the individual responsible for D&I?
Does 4D Molecular Therapeutics Inc conduct 360 degree staff reviews?

Does 4D Molecular Therapeutics Inc have engagement surveys, a culture survey, a pulse survey?

LockedSign up for free to unlock
Does 4D Molecular Therapeutics Inc have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?

Does 4D Molecular Therapeutics Inc disclose the vesting percentage required for performance threshold in the LTIP?

Only SubscribersSubscription required
Has 4D Molecular Therapeutics Inc issued a profit warning in the past 24 months?
Does 4D Molecular Therapeutics Inc report the average age of the workforce?

Does 4D Molecular Therapeutics Inc report internal employee trust metrics such as ENPS?

LockedSign up for free to unlock

Does 4D Molecular Therapeutics Inc permit its workforce to engage in collective bargaining?

LockedSign up for free to unlock

Does 4D Molecular Therapeutics Inc disclose average employee tenure?

Only SubscribersSubscription required

Does 4D Molecular Therapeutics Inc refer to human capital or people risk in its risk disclosures?

Only SubscribersSubscription required

Does 4D Molecular Therapeutics Inc promote decent work conditions in relation to its supply chain?

LockedSign up for free to unlock
Does 4D Molecular Therapeutics Inc allow for Work Councils/Collective Agreements to be formed?

Does 4D Molecular Therapeutics Inc report the number of strikes or work related stoppages?

LockedSign up for free to unlock
Does 4D Molecular Therapeutics Inc have an accelerator or VC vehicle to help deliver innovation?

Does 4D Molecular Therapeutics Inc have a chief innovation officer?

LockedSign up for free to unlock

Does 4D Molecular Therapeutics Inc disclose the ratio of CEO total compensation relative to average employee compensation ?

LockedSign up for free to unlock

Does 4D Molecular Therapeutics Inc disclose its gender pay gap?

Only SubscribersSubscription required
Does 4D Molecular Therapeutics Inc disclose its ethnicity pay gap?
Does 4D Molecular Therapeutics Inc disclose the number of employees in R&D functions?

Does 4D Molecular Therapeutics Inc engage in animal testing?

Only SubscribersSubscription required
Does 4D Molecular Therapeutics Inc engage in stem cell research?

Does 4D Molecular Therapeutics Inc have a commitment to a living wage?

LockedSign up for free to unlock

Does 4D Molecular Therapeutics Inc disclose the vesting schedule of its equity compensation plan?

LockedSign up for free to unlock
Is executive remuneration linked to climate performance?
Does 4D Molecular Therapeutics Inc offer flexible work?

Does 4D Molecular Therapeutics Inc disclose employee diversity metrics?

LockedSign up for free to unlock

Does 4D Molecular Therapeutics Inc disclose employee gender diversity metrics?

LockedSign up for free to unlock
Does 4D Molecular Therapeutics Inc disclose the pay ratio of women to men?
Does 4D Molecular Therapeutics Inc disclose incidents of non-compliance in relation to the health and safety impacts of products and services?

Does 4D Molecular Therapeutics Inc disclose information on fatalities and accidents in the workplace

Only SubscribersSubscription required
Does 4D Molecular Therapeutics Inc report instances of occupational ill health, injury and fatality?

Does 4D Molecular Therapeutics Inc disclose reportable workplace incidents?

LockedSign up for free to unlock

Does 4D Molecular Therapeutics Inc disclose the number of employees, new hires and turnover metrics?

Only SubscribersSubscription required
Does 4D Molecular Therapeutics Inc disclose parental leave metrics?

Does 4D Molecular Therapeutics Inc disclose employee training metrics?

LockedSign up for free to unlock
Does 4D Molecular Therapeutics Inc disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Does 4D Molecular Therapeutics Inc disclose its policies for bribery, corruption, whistle-blower, conflict of interest?

Does 4D Molecular Therapeutics Inc disclose the number of customer privacy complaints?

Only SubscribersSubscription required
Does 4D Molecular Therapeutics Inc disclose incidents of discrimination?

Does 4D Molecular Therapeutics Inc disclose incidents relating human rights, child labour and forced labour?

LockedSign up for free to unlock

Does 4D Molecular Therapeutics Inc disclose incidents of corruption?

Only SubscribersSubscription required

Does 4D Molecular Therapeutics Inc disclose the number of incidents involving the rights of indigenous peoples?

LockedSign up for free to unlock

Does 4D Molecular Therapeutics Inc disclose incidents of non-compliance in relation to product and service information/labelling or marketing communications?

Only SubscribersSubscription required
Did 4D Molecular Therapeutics Inc have a product recall in the last two years?
Does 4D Molecular Therapeutics Inc support suppliers with sustainability related research and development?
Does 4D Molecular Therapeutics Inc have careers partnerships with academic institutions?
Is 4D Molecular Therapeutics Inc involved in embryonic stem cell research?

Does 4D Molecular Therapeutics Inc avoid gender bias in its hiring?

LockedSign up for free to unlock

Does 4D Molecular Therapeutics Inc disclose the number of hours and/or employees/security personnel trained on human rights policies or procedures?

LockedSign up for free to unlock

Have a different question?

Potential Risks for 4D Molecular Therapeutics Inc
These potential risks are based on the size, segment and geographies of the company.

Do you want to create your own ESG Scorecard that you can share with your team members?

Sign up for free
ESG Scorecard with Trendline
green chameleon

1/10 free views/searches used

You're viewing a Free Open ESG Rating.
To access the most comprehensive ESG data experience, Sign up to SEVVA Platform.

4D Molecular Therapeutics, Inc., a clinical-stage gene therapy company, develops product candidates using its adeno-associated viruses vectors. It develops a portfolio of gene therapy product candidates focuses in three therapeutic areas: ophthalmology, cardiology, and pulmonology. The company has three product candidates that are in clinical trials: 4D-125 that is in a Phase 1/2 clinical trial for the treatment of X-linked retinitis pigmentosa; 4D-110 that is in a Phase 1 clinical trial for the treatment of choroideremia; and 4D-310, which is in a Phase 1/2 clinical trial for the treatment of Fabry disease. Its two IND candidates are 4D-150 for the treatment of wet age-related macular degeneration and 4D-710 for the treatment of cystic fibrosis lung disease. 4D Molecular Therapeutics, Inc. has research and collaboration arrangements with uniQure; Benitec; CRF; Roche; CFF; and AstraZeneca. The company was founded in 2013 and is headquartered in Emeryville, California.